期刊文献+

白细胞介素-1基因多态性与原发性高血压关联

Association of the interleukin-1 gene polymorphisms with essential hypertension
下载PDF
导出
摘要 目的研究白细胞介素-1(IL-1)基因多态性与原发性高血压的相关关系.方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术,检测150例原发性高血压患者和160例健康对照者IL-1基因多态性.结果 IL-1α基因-889C/T多态性在两组人群中的分布差异显著(P<0.05);等位基因频率的相对风险分析发现,T等位基因携带者患原发性高血压的风险是C等位基因的2.102倍(OR=2.102,95%CI:1.231~3.590),携带CT+TT基因型的原发性高血压患者收缩压水平显著高于CC基因型者[(168.9±19.8)mmHg比较(160.2±18.9)mmHg],(P<0.05).结论 IL-1α基因-889C/T多态性与原发性高血压的发病具有相关性,其中T等位基因可能是原发性高血压发病的遗传易感基因,携带T等位基因的个体可能通过促进收缩压的升高进而增加了原发性高血压的发病风险. Objective To study the relationship between the polymorphisms of interleukin-1 and essential hypertension in Chinese Han peoples. Methods The polymorphisms of IL-1 gene were analyzed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods in 150 patients with essential hypertension and 160 healthy controls. Results The IL-1 α - 889C/T gene was significantly different( P 〈 0.05). The relative risk suffered from essential hypertension of C allele was 2.102 times of the T allele (OR = 2. 102,95 % CI: 1.231 ~ 3. 590). The systolic blood pressure level of IL-1 α CT + tit genotype carriers was significantly higher than of CC genotype carriers [ ( 168.9 ± 19.8) mmHg vs (160.2 ± 18.9)mmHg, P 〈 0.05]. Conclusion IL-1 α - 889C/T polymorphism was associated with essential hypertension, and T allele may be a risk factor for essential hypertension, in which the IL-1 α T allele carriers may have increased risk by enhancing the systolic blood pressure expression in the pathogenesis of essential hypertension.
出处 《基础医学与临床》 CSCD 北大核心 2005年第12期1130-1134,共5页 Basic and Clinical Medicine
基金 广西科学基金(桂科自0499004) 广西教育厅课题(桂教科200420) 右江民族医学院课题(右医院字200486)
关键词 原发性高血压 白细胞介素-1 基因多态性 T等位基因 essential hypertension interleukin- 1 gene polymorphism
  • 相关文献

参考文献9

  • 1杜冠华.血管内皮细胞损伤机制及保护药物的研究[J].基础医学与临床,2004,24(3):258-263. 被引量:43
  • 2李晓青,张俊武.炎性因子遗传多态性与Alzheimer病[J].基础医学与临床,2004,24(1):7-11. 被引量:8
  • 3Bioque G,Crusius JB,Koutroubakis I,et al.Allelic polymorphism in IL-1β and IL-1 receptor antagonist(IL-1Ra) genes in inflammatory bowel disease[J].Clin Exp Immunol,1995,102(2):379 - 383. 被引量:1
  • 4Witkin SS,Gerber S,Ledger W.Influence of interleukin-1 receptor antagonist gene polymorphism on disease[J].Clin Infectious Dis,2002,34(2):204 - 209. 被引量:1
  • 5Kanemoto K,Kawasaki J,Miyamoto T,et al.Interleukin(IL)-1β,IL-1α,and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy[J].Ann Neurol,2000,47(5):571 - 574. 被引量:1
  • 6Clay FE,Tarlow JK,Cork MJ,et al.Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allelespecific mRNA assessment[J].Hum Genet,1996,97 (6):723- 726. 被引量:1
  • 7Miller SA,Dykes DD,Polesky HF.A simple salting out procedure for extracting DNA from human nucleated cells[J].Nucleic Acid Res,1998,16(3):1215. 被引量:1
  • 8高平进,朱鼎良.原发性高血压的基因治疗[J].基础医学与临床,2002,22(6):494-497. 被引量:11
  • 9Lin RC,Morris BJ.Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension[J].Am J Med Genet,2002,107(4):311 - 316. 被引量:1

二级参考文献58

  • 1任德成,杜冠华,张均田.细胞间粘附分子-1抑制剂的高通量筛选(英文)[J].药学学报,2003,38(6):405-408. 被引量:5
  • 2[1]Phillips MI. Gene therapy for hypertension: the preclinical data [J]. Hypertension, 200i, 38(3 pt 2):543-548. 被引量:1
  • 3[2]Chao J, Chao L. Kallikrein gene therapy: a new strategy for hypertensive diseases [J]. Immunopharmacology, 1997,36: 229-236. 被引量:1
  • 4[3]Wolf Wc, Yoshida H, Agata J, et al. Humen tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardioac remodeling in chronic renal failure[J]. Kidney Int,2000,58:730-739. 被引量:1
  • 5[4]Chao J, Jim L, Lin KF, et al. Adrenomedulin gene delivery reduces blood pressure in spontaneously hypertensive rats [J].Hypertens Res, 1997, 20:2692-2697. 被引量:1
  • 6[5]Dobrzynski E, Yoshida H, Chao J, et al. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats[J]. Immunopharmacology, 1999, 44:57-65. 被引量:1
  • 7[6]Lin KF, Chao L, Chao J. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats [J]. Hum Gene Ther, 1998,9: 1429-1438. 被引量:1
  • 8[7]Sellers KW, Katovich MJ, Gelband CH, et al. Gene tharapy to control hypertension: current studies and future perspectives [J]. Am J Med Sci, 2001, 322 (1):1-6. 被引量:1
  • 9[8]Jeunemaitre Ⅹ, Soubrier F, Kotelevetsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen[J]. Cell,1992,71:169-180. 被引量:1
  • 10[9]Makino K, Sugano M, Ohtsuka S, et al. Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decrease blood pressure in spontaneously hypertensive rats [J].ypertension, 1998,31:1166-1170. 被引量:1

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部